1. Home
  2. ARMP vs ATLX Comparison

ARMP vs ATLX Comparison

Compare ARMP & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • ATLX
  • Stock Information
  • Founded
  • ARMP N/A
  • ATLX 2011
  • Country
  • ARMP United States
  • ATLX Brazil
  • Employees
  • ARMP N/A
  • ATLX N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ARMP Health Care
  • ATLX Industrials
  • Exchange
  • ARMP Nasdaq
  • ATLX Nasdaq
  • Market Cap
  • ARMP 92.4M
  • ATLX 95.1M
  • IPO Year
  • ARMP N/A
  • ATLX N/A
  • Fundamental
  • Price
  • ARMP $2.94
  • ATLX $4.58
  • Analyst Decision
  • ARMP Strong Buy
  • ATLX Strong Buy
  • Analyst Count
  • ARMP 1
  • ATLX 1
  • Target Price
  • ARMP $9.00
  • ATLX $19.00
  • AVG Volume (30 Days)
  • ARMP 12.5K
  • ATLX 421.7K
  • Earning Date
  • ARMP 11-12-2025
  • ATLX 11-07-2025
  • Dividend Yield
  • ARMP N/A
  • ATLX N/A
  • EPS Growth
  • ARMP N/A
  • ATLX N/A
  • EPS
  • ARMP N/A
  • ATLX N/A
  • Revenue
  • ARMP $6,868,000.00
  • ATLX $350,003.00
  • Revenue This Year
  • ARMP $8.43
  • ATLX $22,084.55
  • Revenue Next Year
  • ARMP N/A
  • ATLX N/A
  • P/E Ratio
  • ARMP N/A
  • ATLX N/A
  • Revenue Growth
  • ARMP 84.67
  • ATLX N/A
  • 52 Week Low
  • ARMP $0.90
  • ATLX $3.54
  • 52 Week High
  • ARMP $3.14
  • ATLX $11.89
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 61.74
  • ATLX 42.01
  • Support Level
  • ARMP $2.79
  • ATLX $4.57
  • Resistance Level
  • ARMP $3.03
  • ATLX $5.17
  • Average True Range (ATR)
  • ARMP 0.15
  • ATLX 0.34
  • MACD
  • ARMP 0.02
  • ATLX -0.10
  • Stochastic Oscillator
  • ARMP 72.97
  • ATLX 0.80

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

Share on Social Networks: